clenbuterol has been researched along with kainic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Connor, TJ; Gleeson, LC; Griffin, EW; Harkin, A; Ryan, KJ | 1 |
1 other study(ies) available for clenbuterol and kainic acid
Article | Year |
---|---|
The β2-adrenoceptor agonist clenbuterol elicits neuroprotective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicity.
Topics: Adrenergic beta-3 Receptor Agonists; Animals; Anti-Inflammatory Agents; Apoptosis; Brain-Derived Neurotrophic Factor; Caspase 3; Clenbuterol; Excitatory Amino Acid Agonists; Hippocampus; In Situ Nick-End Labeling; Kainic Acid; Male; Nerve Growth Factors; Neuroprotective Agents; Neurotoxicity Syndromes; Neurotoxins; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Seizures | 2010 |